Welcome to LookChem.com Sign In|Join Free

CAS

  • or

109376-83-2

Post Buying Request

109376-83-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

109376-83-2 Usage

Uses

A potent and selective inhibitor of myosin light chain kinase.

Definition

ChEBI: An N-sulfonyldiazepane resullting from the formal condensation of 5-iodo-1-naphthylsulfonic acid with one of the nitrogens of 1,4-diazepane. It is a selective inhibitor of myosin light chain kinase (EC 2.7.11.18).

Check Digit Verification of cas no

The CAS Registry Mumber 109376-83-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,9,3,7 and 6 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 109376-83:
(8*1)+(7*0)+(6*9)+(5*3)+(4*7)+(3*6)+(2*8)+(1*3)=142
142 % 10 = 2
So 109376-83-2 is a valid CAS Registry Number.
InChI:InChI=1/C15H17IN2O2S/c16-14-6-1-5-13-12(14)4-2-7-15(13)21(19,20)18-10-3-8-17-9-11-18/h1-2,4-7,17H,3,8-11H2

109376-83-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name ML-7

1.2 Other means of identification

Product number -
Other names ML-7 HYDROCHLORIDE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:109376-83-2 SDS

109376-83-2Downstream Products

109376-83-2Relevant articles and documents

A phenotypic approach to probing cellular outcomes using heterobivalent constructs

Bhadoria, Rohit,Lohk, Christer,Ping, Kefeng,Starkov, Pavel,J?rving, Ivar

, p. 4216 - 4219 (2020)

Various conjugation techniques are used to affect the intracellular delivery of bioactive small molecules. However, the ability to track changes in the phenotype when applying these tools remains poorly studied. We addressed this issue by having prepared a focused library of heterobivalent constructs based on Rho kinase inhibitor HA-100. By comparing the induction of the phenotype of interest, cell viability and cellular uptake, we demonstrate that various conjugates indeed lead to divergent cellular outcomes.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 109376-83-2